Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
10/16/24 Merck (MRK) Capvaxive for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
10/15/24 Amgen (AMGN) Uplizna for Myasthenia Gravis (MG) Subscribers Only Subscribers Only Subscribers Only
10/15/24 Jazz (JAZZ) Zepzelca for Small Cell Lung Cancer (SCLC) Subscribers Only Subscribers Only Subscribers Only
10/14/24 GSK (GSK) Depemokimab for Chronic Rhinosinusitis Subscribers Only Subscribers Only Subscribers Only
10/10/24 Stealth Biotherapeutics Elamipretide (Systemic Delivery) for Cardiomyopathy - Dilated Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
09/12/2024 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/30/2024 Subscribers Only Subscribers Only Trial Data - Top-Line Results
10/16/2024 Subscribers Only Subscribers Only Company - Analyst/R&D Update
Now - 10/18/2024 Subscribers Only Subscribers Only Trial Data - Top-Line Results
Now - 10/18/2024 Subscribers Only Subscribers Only Trial Data - Updated Results